Palantir’s Record Quarter Puts the Fundamentals on Display — While Insider Sales and European Skepticism Cloud the Picture

There are quarters that merely beat expectations, and then there are quarters that force a wholesale rethink of what a company is capable of. Palantir Technologies delivered the latter on Monday, posting second-quarter numbers that blew past consensus estimates and prompted a rare wave of coordinated price-target hikes across Wall Street. Yet even as the data-analytics firm basks in its strongest operational showing to date, the stock’s post-earnings surge has been accompanied by a flurry of insider selling and fresh questions about its European expansion — a combination that leaves investors weighing undeniable momentum against nagging concerns.

The Numbers Behind the Hype

Revenue for the second quarter of 2026 came in at $1.94 billion, a 93% jump year over year and comfortably ahead of the $1.81 billion analysts had penciled in. Adjusted earnings per share of $0.41 also topped expectations of $0.34. The headline figures alone would have been enough to justify the enthusiasm, but the underlying metrics tell an even more compelling story.

The US commercial business, long considered the key test of Palantir’s ability to diversify beyond government contracts, grew 149% to $764 million — a segment that has nearly quadrupled since 2024. Total contract value for the quarter hit a record $3.373 billion, with US commercial deals accounting for $2.132 billion of that sum, up 153% from the prior year. The company’s net revenue retention rate climbed to 157% from 150%, while the “Rule of 40” — a standard measure balancing growth and profitability — reached 155%. Adjusted free cash flow margin stood at 63%, or $1.22 billion.

Management responded by lifting full-year guidance for the second consecutive time. Revenue expectations for 2026 now sit at $8.15 billion to $8.16 billion, representing 82% growth, up from the previous range of $7.65 billion to $7.66 billion. The company also raised its US commercial forecast to “more than” $3.42 billion from $3.22 billion, and boosted adjusted free cash flow guidance to $4.50 billion to $4.70 billion. The US commercial backlog more than doubled year over year to $6.24 billion, and Palantir closed 220 deals exceeding $1 million — 73 of them above the $10 million threshold.

New business wins added further weight to the quarter: a partnership with law firm Kirkland & Ellis was expanded to $500 million, a $300 million framework agreement was signed with the US Department of Agriculture, and a collaboration with Mercury Systems was announced to automate material planning and manufacturing processes for defense programs under a US-government-backed arrangement. In the media space, USA Today Co. reportedly agreed to use Palantir’s AI software to analyze reader data and automate monetization, per Poynter.

Wall Street Rushes to Reprice

The analyst community responded with unusual unanimity. Citi lifted its price target from $200 to $245, citing accelerated revenue growth and an upgraded US commercial outlook of 134%, up from 120%. Deutsche Bank went a step further, upgrading the stock from Hold to Buy while keeping its $200 target, describing the report as “extraordinary.” A wave of other institutions — including Goldman Sachs, UBS, Mizuho, DA Davidson, Truist, Piper Sandler, and Northland — followed with target increases ranging from $200 to $230.

Should investors sell immediately? Or is it worth buying Palantir?

CEO Alex Karp added fuel to the bullish narrative in a CNBC interview, suggesting the growth pace would persist for “at least another 18 months.” The confidence is backed by operational momentum that extends well beyond the headline revenue figure.

The Counterweights: Insider Sales and European Hurdles

But the euphoria has not gone unchallenged. Within 72 hours of the earnings release, Karp and other directors sold more than $150 million worth of stock, according to regulatory filings cited in media reports — a move that came right as the shares were climbing roughly 28% over a seven-day stretch. Insider sales following strong results are not inherently alarming; they often reflect portfolio diversification or pre-arranged trading plans. Still, the timing, squarely within the post-earnings rally, invites questions about how much near-term upside management itself sees.

A second concern comes from across the Atlantic. Defense authorities in Switzerland and Germany have reportedly declined contract offers from Palantir after risk assessments concluded that the company’s architecture could not technically rule out access by US intelligence agencies under the CLOUD Act. For a firm increasingly reliant on government and military business, such trust deficits in security-sensitive European markets could prove more consequential than they might appear at first glance.

A Stock That Demands Strong Nerves

The market’s reaction to the quarter was explosive — shares jumped roughly 30% immediately after the release — but the enthusiasm has already cooled somewhat. The stock recently closed at €135.46, down 1.25% on the day, and remains about a quarter below its 52-week high of €179.98. Despite the pullback, the shares still show a gain of 26.93% over the past week. With an annualized 30-day volatility approaching 97%, this is a stock that demands considerable fortitude from its holders.

The tension is hard to miss: operational excellence on one side, a valuation debate and trust concerns on the other. Palantir’s fundamental story has rarely looked stronger — the growth rates, cash flow margins, and repeated guidance raises speak for themselves. But the combination of insider selling at the peak of the rally and tangible European security reservations suggests the current share price may already reflect much of the good news. For investors, the question is not whether Palantir is executing — it clearly is — but whether the market’s expectations have once again run ahead of even this remarkable trajectory.